NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









GAIA BioMedicine Inc.

GAIA BioMedicine Inc.

Private
FukuokaHealthcare & Life Scienceshttps://gaia-biomed.com/

Last Round

Series D

Jul 11, 2025

Total Funding Raised

$30.12M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

GAIA BioMedicine Inc. is a biopharmaceutical company that develops off-the-shelf, NK-like cell therapies to treat solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

allogeneic cell therapyoff-the-shelf cell therapyNK cell therapycellular immunotherapysolid tumorsnon-genetically modifiedimmuno-oncologyclinical stage biotechcancer therapyfulamleucelcell therapy manufacturingneuroblastomapediatric cancerGAAAP platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GAIA BioMedicine Inc. Comparables

Compare GAIA BioMedicine Inc. with similar companies based on industry and business-model similarity.

GAIA BioMedicine Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

GAIA BioMedicine Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJul 11, 2025
Series BSep 21, 2021
Series AFeb 4, 2020
StrategicFeb 13, 2018

GAIA BioMedicine Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors grew 255% MoM, from 11 to 39.

  • Jul 11, 2025

    $12M round led by UntroD Nomura Crossover Impact Fund.

GAIA BioMedicine Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GAIA BioMedicine Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GAIA BioMedicine Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersFukuoka
Employee Range2
Year Founded2015
Last FundingJul 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.